Heavy Drinking Can Damage Every Part of the Eye
Jun 24, 2022 · Tori Rodriguez, MA, LPC, AHC, is an Atlanta-based journalist, licensed psychotherapist, and Ayurvedic health coach, creator of the body-positive wellness company Bettie Page Fitness, and author of 2 books – The Little Book of Bettie: Taking a Page from the Queen of Pinups and Bettie Page: The Lost Years.
Faricimab Therapy Shows Stable Vision At 1 Year - Ophthalmology …
Dec 3, 2024 · With intravitreal faricimab therapy, a real-world cohort achieved steady mean treatment extension and reduced subretinal fluid (SRF), while preserving vision — despite their neovascular age-related macular degeneration (nAMD) being chronic and having previously received other maintenance biologics, according to a study in Retina.. Investigators reviewed charts of 217 participants (263 eyes ...
Restoring the Retina: Coming Advancements to Repair Structure …
Feb 16, 2021 · The ophthalmic literature is replete with studies that open with frightening statistics on the rapid expansion of retinal diseases. Researchers frequently identify age-related macular degeneration (AMD) as the leading cause of blindness in the United States.
Preservative-Free Sodium Hyaluronate Drop Improves Dry Eye for …
Nov 20, 2023 · Preservative-free sodium hyaluronate (0.4%) eye drops in different dosages effectively alleviates signs and symptoms of dye eye disease (DED) after 1 month of treatment in approximately 50% of patients, according to a study published in Clinical Ophthalmology.. Researchers investigated the effectiveness of the preservative-free sodium hyaluronate drops in a randomized, parallel assignment ...
Photobiomodulation: An Emerging Dry AMD Treatment
Mar 20, 2024 · In exudative age-related macular degeneration (wet AMD), significant strides — such as the development of anti-vascular endothelial growth factor (anti-VEGF) therapies — have pushed the treatment possibilities forward and rewritten the likely course of the disease for many patients. However, for most patients, AMD is nonexudative (dry), and treatments for those patients remain largely ...
FDA Drug Approval Decisions Expected in December 2024
Nov 15, 2024 · The Prescription Drug User Fee Act (PDUFA) date refers to the deadline set by the US Food and Drug Administration (FDA) for reviewing a New Drug Application (NDA) or Biologics License Application (BLA) and making a final decision on marketing approval. The typical period for review is 10 months after the drug application has been accepted by the Agency.
Photobiomodulation Treatment for Dry AMD Approved By FDA ...
Nov 15, 2024 · A photobiomodulation therapy device has received approval by the US Food and Drug Administration (FDA) to be marketed for the treatment of nonexudative (dry) age-related macular degeneration (AMD), according to statements from the FDA and the manufacturer.The device allows physicians the opportunity to offer a noninvasive treatment for dry AMD with a low-level laser therapy (LLLT) technology. 1,2
FDA Extends Review of CNTF Ocular Implant for Macular …
Nov 20, 2024 · The Food and Drug Administration (FDA) has extended the review period for the Biologics License Application (BLA) for NT-501 (revakinagene taroretcel) in the treatment of macular telangiectasia type 2 (MacTel).
Uveitis Burden in The US Higher Than Previously Believed ...
Oct 20, 2024 · The uveitis burden may be higher in the United States than previously thought. Uveitis is associated with approximately a quarter of all cases of legal blindness, and the disease’s prevalence within the United States appears to be larger than earlier studies suggest, according to research presented at the American Academy of Ophthalmology, held in Chicago, October 18 to 21, 2024.
Reproxalap Under Review Again for Dry Eye Disease
Nov 18, 2024 · References: Aldeyra Therapeutics announces FDA acceptance for review of reproxalap New Drug Application for the treatment of dry eye disease, expands AbbVie option agreement.